Engineered exosomes with KrasG12D specific siRNA in pancreatic cancer: a phase I study with immunological correlates

Valerie S. LeBleu(The University of Texas MD Anderson Cancer Center), Raghu Kalluri(The University of Texas MD Anderson Cancer Center)
Nature Communications
September 30, 2025
10.1038/s41467-025-63718-2
Cited by 28

Related Papers

The basics of epithelial-mesenchymal transition
|Journal of Clinical Investigation|2009|10.1k
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
|Nature|2015|2.9k
Epithelial-mesenchymal transition and its implications for fibrosis
|Journal of Clinical Investigation|2003|2.2k
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
|Nature Medicine|2007|2.2k
The biology and function of exosomes in cancer
|Journal of Clinical Investigation|2016|1.9k